On 5th December at the latest meeting of the Standing Committee. In a press release from the Commission they current status and details of the health claims voted into law and those awaiting a final decision, what will happen re enforcement etc are discussed….More to follow! SOURCE: http://europa.eu/rapid/pressReleasesAction.do?reference=MEMO/11/868
After 3 long years the 13.1 list of health claims have been reviewed by EFSA’s NDA panel….see there comments here! http://www.efsa.europa.eu/en/press/news/110728.htm
In EFSA 5th batch released today some of the sports nutrition markets biggest ingredients have taken a pounding. The following is a brief overview of the opinions on this batch of health claims as they relate to the weight loss and sports nutrition industry…. . Sports Nutrition outcomes: HMB – Rejected RIBOSE – Rejected SODIUM [...]
According to a recent communication from the EC, member states will be allowed to forward for further EFSA assessment claims made on micro-organism (not sufficiently characterised). Furthermore, claims for which EFSA concluded that “the evidence provided is insufficient to establish cause and effect relationship” rather than “a cause and effect relationship has not been established” [...]
The French Agency for Food, Environmental and Occupational Health & Safety (ANSES) on the 9th December 2010 launched a nutritional vigilance scheme for novel foods, fortified foods, food supplements and foodstuffs intended for specific diets. The scheme will enable authorities to identify possible adverse effects related to their consumption and to undertake targeted expert appraisals. [...]
The opinons will heavily influence the just a quick update that the next batch of EFSA opinions under article 13.1 are released next monday. The list will see 808 claims assessed and reduced to 75 scientific opinions and will include a focus on the sports market with claims on beta-alanine, whey protines, glutamine, BCAA, CLA, [...]
EFSA has launched a public consultation on the draft guidance on the scientific requirements for health claims related to gut and immune function. The document has been drawn from EFSA’s scientific opinions on health claims related to the gastrointestinal tract and immune system. Thus, it represents the views of the NDA Panel, based on the [...]
The commission has today announced that it has intended to restructure its process of the progressive adoption of the list of health claims on foods, ingredients and dietary supplements. According to the commission’s press release opinions on all claims other than botanicals will be now be released (and likley adopted) in one final batch. Following [...]
With EFSA rejecting almost 80% of health claims submitted under article 13.1, industry is rightly concerned. However, these opinions are not yet law. Although EFSA has given its opinion and the commission intends to publish the list, the European parliament has still 3 months to look at the opinions and their implementation through the regulatory [...]
Gaining a health claim is one thing but gaining one that makes sense to the general public is another. As part of the general conditions of article 13 claims (Art 13(1)ii) a health claim must be ‘well understood by the average consumer’. Claims must also protect the consumer from being misled, and balancing these two [...]
Twitter